Diabetic ketoacidosis: Difference between revisions
imported>Howard C. Berkowitz No edit summary |
imported>Robert Badgett No edit summary |
||
| Line 2: | Line 2: | ||
In [[medicine]], '''diabetic ketoacidosis''' ('''DKA''') is a type of metabolic [[acidosis]] that is a "life-threatening complication of diabetes mellitus, primarily of [[Type 1 Diabetes Mellitus]] with severe [[insulin]] deficiency and [[hyperglycemia]]. It is characterized by excessive [[lipolysis]], oxidation of fatty acids, production of ketone bodies, a sweet smell to the breath ([[ketosis]];) [[dehydration]]; and depressed consciousness leading to [[coma]].<ref>{{MeSH}}</ref> | In [[medicine]], '''diabetic ketoacidosis''' ('''DKA''') is a type of metabolic [[acidosis]] that is a "life-threatening complication of diabetes mellitus, primarily of [[Type 1 Diabetes Mellitus]] with severe [[insulin]] deficiency and [[hyperglycemia]]. It is characterized by excessive [[lipolysis]], oxidation of fatty acids, production of ketone bodies, a sweet smell to the breath ([[ketosis]];) [[dehydration]]; and depressed consciousness leading to [[coma]].<ref>{{MeSH}}</ref> | ||
Treatment begins with fluid replacement; insulin is not started immediately. It is often secondary to infection or other comorbidity, which must be diagnosed and treated. <ref name=eMedicine>{{citation | Treatment begins with fluid replacement; insulin is not started immediately. It is often secondary to infection or other comorbidity, which must be diagnosed and treated.<ref name="pmid20048266">{{cite journal| author=Wilson JF| title=In clinic. Diabetic ketoacidosis. | journal=Ann Intern Med | year= 2010 | volume= 152 | issue= 1 | pages= ITC1-1, ITC1-2, ITC1-3,ITC1-4, ITC1-5, ITC1-6, ITC1-7, ITC1-8, ITC1-9, ITC1-10, ITC1-11, ITC1-12, ITC1-13, ITC1-14, ITC1-15, table of contents; quiz ITC1-16 | pmid=20048266 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=20048266 | doi=10.1059/0003-4819-152-1-201001050-01001 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name=eMedicine>{{citation | |||
| url = http://emedicine.medscape.com/article/766275-print | | url = http://emedicine.medscape.com/article/766275-print | ||
| journal = eMedicine | date = February 12, 2008 | author = Rucker DW | | journal = eMedicine | date = February 12, 2008 | author = Rucker DW | ||
Revision as of 00:15, 19 January 2010
In medicine, diabetic ketoacidosis (DKA) is a type of metabolic acidosis that is a "life-threatening complication of diabetes mellitus, primarily of Type 1 Diabetes Mellitus with severe insulin deficiency and hyperglycemia. It is characterized by excessive lipolysis, oxidation of fatty acids, production of ketone bodies, a sweet smell to the breath (ketosis;) dehydration; and depressed consciousness leading to coma.[1]
Treatment begins with fluid replacement; insulin is not started immediately. It is often secondary to infection or other comorbidity, which must be diagnosed and treated.[2][3]As it is treated, DKA converts from a high anion gap metabolic acidosis to a normal anion gap metabolic acidosis due to "excretion of ketone anions in the urine"[4], especially if excreted with sodium or potassium cations.
References
- ↑ Anonymous (2024), Diabetic ketoacidosis (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Wilson JF (2010). "In clinic. Diabetic ketoacidosis.". Ann Intern Med 152 (1): ITC1-1, ITC1-2, ITC1-3,ITC1-4, ITC1-5, ITC1-6, ITC1-7, ITC1-8, ITC1-9, ITC1-10, ITC1-11, ITC1-12, ITC1-13, ITC1-14, ITC1-15, table of contents; quiz ITC1-16. DOI:10.1059/0003-4819-152-1-201001050-01001. PMID 20048266. Research Blogging.
- ↑ Rucker DW (February 12, 2008), "Diabetic ketoacidosis", eMedicine
- ↑ Oh MS, Carroll HJ, Goldstein DA, Fein IA (December 1978). "Hyperchloremic acidosis during the recovery phase of diabetic ketosis". Ann. Intern. Med. 89 (6): 925–7. PMID 102229. [e]